About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 2NCT01726270

An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms

Multicenter trial conducted in Pharmacy retail centers

Lead sponsor: Boehringer Ingelheim•18 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Boehringer Ingelheim

Age

18 - 100 years

Sex

MALE

Healthy Volunteers

No

Inclusion Criteria

•1. Men 18 years of age and older.
•2. Able to speak, read and understand English.
•3. Willing to participate in the study and voluntarily sign an informed consent document.

Exclusion Criteria

•1\. Subject or anyone in their household is currently employed by a marketing or marketing research company, and advertising agency or public relations firm, a pharmacy or pharmaceutical company, a manufacturer of medicines, a managed care or health insurance company as a healthcare professional or healthcare practice.

Related studies

Reducing Disparities in Urinary Control Symptoms for Minority Women

NCT06798311 · Urinary Incontinence (UI), Lower Urinary Tract Symptoms (LUTS), and more

RCT on Running Water Sound During Urodynamic

NCT07451548 · Lower Urinary Tract Symptoms (LUTS)

HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer

NCT03802851 · Prostate Cancer, Lower Urinary Tract Symptoms

Omega Study: Evaluation of the Safety and Efficacy of the Omega System for the Treatment of BPH

NCT04627701 · Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms

Bipolar Resection vs Enucleation of Prostate

NCT06983444 · Benign Prostatic Hyperplasia (BPH) Requiring Surgical Resection, Benign Prostatic Hyperplasia With Outflow Obstruction, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 27, 2020Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment689

Start dateNov 2012

Last updatedMar 27, 2020

Condition

Lower Urinary Tract Symptoms

Locations shown

Boehringer Ingelheim Investigational Site

Hoover, Alabama

Boehringer Ingelheim Investigational Site

Mesa, Arizona

Boehringer Ingelheim Investigational Site

Encino, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 27, 2020Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions